Aristides G Eliopoulos Selected Research

neorogioltriol

2/2019

Neorogioltriol and Related Diterpenes from the Red Alga Laurencia Inhibit Inflammatory Bowel Disease in Mice by Suppressing M1 and Promoting M2-Like Macrophage Responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aristides G Eliopoulos Research Topics

Disease

17	Neoplasms (Cancer) 02/2022 - 01/2003
7	Carcinoma (Carcinomatosis) 02/2022 - 01/2004
6	Carcinogenesis 10/2018 - 06/2009
4	Inflammation (Inflammations) 01/2016 - 01/2010
3	Obesity 01/2022 - 01/2019
3	Infections 01/2021 - 10/2011
3	Latent Infection 10/2003 - 05/2002
2	Body Weight (Weight, Body) 01/2022 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2021
2	COVID-19 12/2021 - 01/2021
2	Neutropenia 10/2017 - 05/2011
2	Neoplasm Metastasis (Metastasis) 12/2011 - 08/2010
2	Breast Neoplasms (Breast Cancer) 08/2010 - 06/2009
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 06/2022
1	Drug-Related Side Effects and Adverse Reactions 03/2022
1	Insulin Resistance 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Genetic Risk Score 01/2022
1	Hypercholesterolemia 01/2021
1	Atherosclerosis 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2019
1	Colitis 02/2019
1	Sepsis (Septicemia) 01/2019
1	Lung Injury 01/2019
1	Hepatitis 01/2016
1	Genomic Instability 01/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2014
1	Lung Neoplasms (Lung Cancer) 04/2013
1	Polyps 05/2012

Drug/Important Bio-Agent (IBA)

9	CD40 Ligand (CD40L)IBA 02/2022 - 01/2004
8	Proteins (Proteins, Gene)FDA Link 06/2022 - 05/2002
7	Phosphotransferases (Kinase)IBA 06/2022 - 10/2003
7	NF-kappa B (NF-kB)IBA 06/2009 - 05/2002
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2011 - 09/2002
5	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2005 - 01/2004
4	LigandsIBA 02/2022 - 01/2003
3	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 02/2022 - 05/2011
3	TNF Receptor-Associated Factor 2 (TRAF2)IBA 11/2005 - 05/2002
3	Membrane Proteins (Integral Membrane Proteins)IBA 10/2003 - 05/2002
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 01/2021
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 01/2005
2	CytokinesIBA 02/2019 - 01/2016
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 06/2015 - 06/2005
2	Fluorouracil (Carac)FDA LinkGeneric 03/2014 - 01/2005
2	EpitopesIBA 05/2012 - 01/2005
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2011 - 09/2002
2	GalactosamineIBA 08/2003 - 09/2002
1	Anaplastic Lymphoma KinaseIBA 06/2022
1	Pharmaceutical PreparationsIBA 03/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2022
1	Interleukin-6 (Interleukin 6)IBA 02/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2022
1	Coffee FDA Link 01/2022
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2022
1	Caffeine (No Doz)FDA LinkGeneric 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Apolipoprotein E4IBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2020
1	neorogioltriolIBA 02/2019
1	DiterpenesIBA 02/2019
1	Insulin (Novolin)FDA Link 01/2019
1	RNA (Ribonucleic Acid)IBA 10/2018
1	Immunoglobulins (Immunoglobulin)IBA 10/2017
1	Galactosylceramides (Galactocerebrosides)IBA 01/2016
1	ChromatinIBA 01/2016
1	RibonucleoproteinsIBA 01/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	Antiviral Agents (Antivirals)IBA 06/2015
1	VaccinesIBA 10/2014
1	Urethane (Ethyl Carbamate)IBA 04/2013
1	Adenosine Triphosphate (ATP)IBA 05/2012
1	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2012
1	Interleukin-10 (Interleukin 10)IBA 05/2012
1	CalreticulinIBA 05/2012
1	HMGB1 Protein (HMG1)IBA 05/2012
1	Cadherins (E-Cadherin)IBA 12/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2011
1	Interleukin-1 (Interleukin 1)IBA 05/2011
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2011
1	Caspase 8 (Caspase-8)IBA 02/2011
1	IntegrinsIBA 08/2010
1	Small Interfering RNA (siRNA)IBA 08/2010
1	Integrin alpha3beta1IBA 08/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2010
1	OvalbuminIBA 01/2010
1	Immunoglobulin E (IgE)IBA 01/2010

Therapy/Procedure

6	Therapeutics 02/2022 - 01/2004
3	Ligation 10/2008 - 01/2004
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2005
2	Nutrition Therapy (Medical Nutrition Therapy) 01/2022 - 01/2022
1	Precision Medicine 01/2022
1	Mediterranean Diet 01/2021
1	Biological Therapy 01/2021